echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Hormone-free male contraceptives are 99% effective in preclinical trials and are expected to enter human trials by the end of the year

    Hormone-free male contraceptives are 99% effective in preclinical trials and are expected to enter human trials by the end of the year

    • Last Update: 2022-04-25
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com


    On Wednesday, a team of scientists said they had developed a male oral contraceptive that was 99 percent effective in mice with no apparent side effects, and is expected to enter human trials by the end of this year


    The findings, to be presented at the Spring Meeting of the American Chemical Society, mark a key step forward in expanding contraceptive choices and accountability for men


    Md Abdullah Al Noman, a graduate student at the University of Minnesota who will lead the study, told AFP that researchers have been interested in male contraceptives since they were first approved for women in the 1960s


    "Multiple studies have shown that men are willing to share the responsibility for birth control with their partners," he said, but so far there have only been two effective options: condoms or vasectomy


    Vasectomy reversal surgery is expensive and not always successful


    Female birth control pills use hormones to disrupt the menstrual cycle, while historical efforts to develop male birth control pills have focused on the male hormone testosterone


    The problem with this approach, however, is that it can lead to side effects such as weight gain, depression and elevated levels of LDL (a type of cholesterol), which increases the risk of heart disease


    Female birth control pills also have side effects, including the risk of blood clots — but since women can become pregnant without birth control, the risk is calculated differently


    Hormone-Free Contraceptives

    To develop a non-hormonal drug, Noman, who works in Professor Gunda Georg's lab, targeted a protein called retinoic acid receptor (RAR) alpha


    In the body, vitamin A is converted into different forms, including retinoic acid, which plays an important role in cell growth, sperm formation, and embryonic development


    Retinoic acid needs to interact with RAR-alpha for these functions, and laboratory experiments have shown that mice without the RAR-alpha gene are sterile


    In their work, Noman and Georg developed a compound that blocks the effects of RAR-alpha


    "If we know what a keyhole looks like, then we can make a better key -- that's where computational modeling comes in," Noman said


    Their chemical, YCT529, was also designed to interact with RAR-alpha, but not the other two related receptors, RAR-beta and RAR-gamma, to minimize potential side effects


    Will be listed in 5 years

    When administered orally to male mice for 4 weeks, YCT529 greatly reduced sperm count and effectively prevented 99 percent of pregnancies in mating assays


    The researchers monitored weight, appetite and overall activity and found no apparent adverse effects, although the mice certainly couldn't report side effects like headaches or mood changes
    .

    Four to six weeks after stopping the drug, the mice were able to produce male offspring again
    .

    Georg said the team, which is funded by the National Institutes of Health and the Male Contraception Initiative, is working with a company called YourChoice Therapeutics and plans to launch a 2022 or 2022 release date.
    Human trials begin in the fourth quarter
    .

    "I'm optimistic this will move forward quickly,
    " she said, envisioning a timetable that could go public in five years or less
    .

    "No one can guarantee that it will work .
    .
    .
    but I would be really surprised if we didn't see this effect in humans," she added
    .

    An ongoing question about the future of male contraceptives is whether women will trust men to use them
    .

    But surveys show that most women actually have confidence in their partners, and a significant number of men say they are open to drug treatment
    .

    "Male contraceptives will be part of mixed contraceptive methods, offering new options for both men and women to provide contraceptives in any way they see fit
    .
    "



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.